These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1375508

  • 1. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [Abstract] [Full Text] [Related]

  • 2. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E, Thorsen S.
    Biochem J; 1981 Sep 01; 197(3):619-28. PubMed ID: 6459779
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
    Humphries JE, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1993 Jan 01; 13(1):48-55. PubMed ID: 7678497
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK, Yoo JK, Webb DJ, Gonias SL.
    Biochem J; 1993 Feb 01; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [Abstract] [Full Text] [Related]

  • 5. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K, Komorowicz E, Machovich R.
    Blood Coagul Fibrinolysis; 1994 Dec 01; 5(6):905-11. PubMed ID: 7534486
    [Abstract] [Full Text] [Related]

  • 6. Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin.
    Christensen U.
    Biochim Biophys Acta; 1978 Sep 11; 526(1):194-201. PubMed ID: 150862
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM, Pizzo SV.
    Biochem J; 1992 Aug 15; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [Abstract] [Full Text] [Related]

  • 8. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK, Wolf B, Gonias SL.
    Thromb Res; 1990 Aug 01; 59(3):449-62. PubMed ID: 1700488
    [Abstract] [Full Text] [Related]

  • 9. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB, Gaĭsarian ES, Snitko IaE, Varfolomeev SD.
    Bioorg Khim; 1994 Feb 01; 20(2):182-9. PubMed ID: 8155080
    [Abstract] [Full Text] [Related]

  • 10. The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes.
    Cederholm-Williams SA, Swain A.
    Thromb Res; 1979 Feb 01; 16(5-6):705-13. PubMed ID: 160626
    [No Abstract] [Full Text] [Related]

  • 11. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF, Houng A, Reed GL.
    Biochemistry; 2000 Apr 25; 39(16):4740-5. PubMed ID: 10769130
    [Abstract] [Full Text] [Related]

  • 12. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M, Zenker M.
    Blood Coagul Fibrinolysis; 2003 Feb 25; 14(2):203-9. PubMed ID: 12632033
    [Abstract] [Full Text] [Related]

  • 13. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B, Rojas G, Vranckx R, Lijnen HR, Anglés-Cano E.
    FEBS J; 2005 Jul 25; 272(13):3387-400. PubMed ID: 15978044
    [Abstract] [Full Text] [Related]

  • 14. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K, Léránt I, Tenekejiev K, Machovich R.
    J Biol Chem; 1994 Jun 24; 269(25):17030-4. PubMed ID: 7516329
    [Abstract] [Full Text] [Related]

  • 15. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C.
    Blood Coagul Fibrinolysis; 1994 Aug 24; 5(4):537-42. PubMed ID: 7531000
    [Abstract] [Full Text] [Related]

  • 16. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA, Mangel WF.
    Biochemistry; 1985 Jun 18; 24(13):3279-86. PubMed ID: 3161540
    [Abstract] [Full Text] [Related]

  • 17. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A, Takada Y.
    Thromb Res; 1989 Sep 15; 55(6):717-25. PubMed ID: 2551068
    [Abstract] [Full Text] [Related]

  • 18. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M, Zenker M, Gaffney PJ.
    Thromb Res; 2000 Nov 15; 100(4):341-51. PubMed ID: 11113278
    [Abstract] [Full Text] [Related]

  • 19. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK, Gonias SL.
    Biochem J; 1991 Apr 01; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [Abstract] [Full Text] [Related]

  • 20. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
    Longstaff C, Gaffney PJ.
    Biochemistry; 1991 Jan 29; 30(4):979-86. PubMed ID: 1703440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.